Patent · US Active

ZCYTOR17 heterodimeric cytokine receptor polynucleotides

US8647866B2 · kind B2 · utility

11Cited by
6References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 14, 2013
Grant dateFeb 11, 2014
Priority date
Expiry dateJan 14, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing multimeric or heterodimer cytokine receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. The present invention also includes methods for producing the multimeric or heterodimeric cytokine receptor, uses therefor and antibodies thereto.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.